Robert Jacks
President & CEO at Sparrow Pharmaceuticals, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Sparrow Pharmaceuticals, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
President & CEO
-
Jan 2021 - 3 years
New York City Metropolitan Area Sparrow Pharmaceuticals is a clinical stage, private biopharmaceutical company developing targeted therapeutics for serious disorders of steroid excess.
-
-
-
Indalo Therapeutics
-
United States
-
Biotechnology
-
1 - 100 Employee
-
President & CEO
-
Nov 2018 - Aug 2020
Cambridge, MA Indalo Therapeutics is a preclinical-stage biotechnology company backed by Atlas and F-Prime dedicated to improving the lives of patients suffering from debilitating fibrotic diseases.
-
-
-
OrbiMed
-
United States
-
Investment Management
-
1 - 100 Employee
-
Entrepreneur In Residence
-
Jul 2018 - Oct 2018
Greater New York City Area OrbiMed is a leading healthcare focused investment firm with over $14 billion under management across public and private company investments worldwide.
-
-
-
Symbiomix Therapeutics, LLC
-
United States
-
Pharmaceutical Manufacturing
-
Co-Founder, President & Chief Financial Officer
-
Jan 2013 - Mar 2018
Greater New York City Area Symbiomix is a late-stage biopharmaceutical company with a focus on women's health backed by OrbiMed, F-Prime, and HBM Partners. Symbiomix developed Solosec™ from pre-clinical candidate through NDA approval in less than five years before being sold to Lupin Inc. in 2017.
-
-
-
-
President & Founder
-
Jan 2009 - Dec 2012
Greater New York City Area Professional services to the biotechnology and pharmaceutical industries in the areas of business development, fund raising, commercial analysis, valuation, and product development strategy. Clients include: Invida Pharmaceuticals, a specialty pharmaceutical company with operations across Asia Pacific; SMC Biotechnology, a private company with innovative regenerative medicine technology; Alliqua, a biomedical company focused on the development, manufacturing and marketing of proprietary… Show more Professional services to the biotechnology and pharmaceutical industries in the areas of business development, fund raising, commercial analysis, valuation, and product development strategy. Clients include: Invida Pharmaceuticals, a specialty pharmaceutical company with operations across Asia Pacific; SMC Biotechnology, a private company with innovative regenerative medicine technology; Alliqua, a biomedical company focused on the development, manufacturing and marketing of proprietary products in wound healing; and PopTest, a start-up with a non-invasive and user-friendly diagnostic platform. Show less
-
-
-
Tobira Therapeutics
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Senior Vice President, Corporate Development
-
Jan 2011 - Mar 2012
San Francisco Bay Area Leadership Team member for private biotech with a CCR5/CCR2 antagonist in development for HIV. Led business development efforts, participated in Series B financing.
-
-
-
ACT Biotech, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President, Head of Corporate Development
-
Jan 2009 - Dec 2010
San Francisco Bay Area Responsible for partnering strategy and execution for venture financed oncology spin-out from Bayer Healthcare with four oral kinase inhibitor programs.
-
-
-
Pfizer Inc
-
United States
-
Hospitals and Health Care
-
Director, Worldwide Business Development
-
Oct 2005 - Jul 2007
New York, NY Led Licensing Leadership Teams for Infectious Diseases, Oncology and Ophthalmology. Created sourcing strategies and plans, identified and evaluated opportunities, formed and led cross-functional analysis teams, presented to management and interfaced with potential partners.
-
-
Sr. Manager, New Product Development
-
Dec 2002 - Oct 2005
New York, NY Led commercial assessment teams and early marketing strategy for Infectious Diseases and Oncology. Designed clinical development and regulatory strategies for pipeline products. Recommended target launch positioning and investment plans to create differentiation and maximize value.
-
-
Associate, Corporate Finance
-
Jul 2001 - Dec 2002
New York, NY
-
-
-
BE&K Inc
-
United States
-
Project Engineer
-
Jun 1995 - Aug 1999
Birmingham, Alabama Area
-
-
Education
-
Columbia Business School
MBA, Finance -
Stanford University
MSE, Civil Engineering -
Duke University
BSE, Civil & Environmental Engineering